NewsBenzingaThe FDA Clears United Therapeutics' Investigational New Drug Application To Proceed With SUMMIT Trial Of Treprostinil Soft Mist Inhaler In Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease The FDA Clears United Therapeutics' Investigational New Drug Application To Proceed With SUMMIT Trial Of Treprostinil Soft Mist Inhaler In Pulmonary Hypertension Associated With Chronic Obstructive Pulmonary Disease Benzinga 2026.10.19 11:09 (GMT+0) Open on Benzinga Other news Jensen Huang's GTC Berlin Keynote: NVIDIA Shifts from "Selling GPUs" to "Selling AI Factories," Vera Rubin Enters Full Production Anthropic releases new Claude API version, removing sampling parameters like temperature Tesla Doesn’t Sell a Single Bitcoin in Q3 as Crypto Stash Jumps 42% to $962 Million South Korea's IT and cybersecurity industry urgently responding to critical PHP vulnerability Ethereum spot ETFs saw $14.955 million in total net inflows yesterday, turning to net inflows after 5 consecutive days of net outflows Bitcoin spot ETFs saw $528 million in total net inflows yesterday, marking 3 consecutive days of net inflows
Jensen Huang's GTC Berlin Keynote: NVIDIA Shifts from "Selling GPUs" to "Selling AI Factories," Vera Rubin Enters Full Production
Ethereum spot ETFs saw $14.955 million in total net inflows yesterday, turning to net inflows after 5 consecutive days of net outflows
Bitcoin spot ETFs saw $528 million in total net inflows yesterday, marking 3 consecutive days of net inflows
